공시 • Apr 02
Cryomass Technologies Inc. announced delayed annual 10-K filing On 04/01/2025, Cryomass Technologies Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • Apr 02
Cryomass Technologies Inc. announced delayed annual 10-K filing On 04/01/2024, Cryomass Technologies Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • Nov 15
Cryomass Technologies Inc. announced delayed 10-Q filing On 11/14/2023, Cryomass Technologies Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Jul 08
CryoMass Technologies Inc. Provides Update on Commercial Processing Phase CryoMass Technologies Inc. announced the successful transition from beta testing to commercial-level processing of its Trichome Separation Beta unit, also known as "CryoSift Separator". Since acquiring all intellectual property from CryoCann USA Corp, CryoMass has achieved remarkable strides in advancing and protecting its proprietary technology. Prior to the CryoCann asset acquisition, the technology had undergone six years of intensive research and development, but it had not been validated at an industrial scale. CryoMass has now achieved a major milestone by successfully designing and constructing an industrial-scale Beta system, which has undergone rigorous testing across multiple phases. This comprehensive journey, starting from the initial industrial design to the completion and testing of the first prototype, hasaid a solid foundation for CryoMass to embark on commercial-level processing. This achievement marks a significant leap forward for the Company. Following the completion of the CryoSift Separator Beta unit's build, CryoMass initially installed the unit at RedTape Core Partners LLC's licensed Coastal Refinement Solutions ("Coastal"), California, processing center in mid-December, pursuant to a multi-state licensing agreement that previously announced CryoMass, in collaboration with Coastal's extraction team, conducted trial runs on the Beta unit and identified areas for optimization to enhance performance. After completing the necessary modifications, a second series of biomass test runs began. During the second series of runs, the company focussed on evaluating the system's reliability, performance, and safety, established optimal cleaning and maintenance procedures, and determined the final design for the first serialized CryoSift Separator build. The company also captured efficiency data and started to establish Standard Operating Procedures (SOPs) for processing CryoSift (trichomes separated using the Company‘s proprietary method) in either a hydrocarbon-based extraction system or for producing solventless extracts. Throughout this phase, the CryoMass team closely monitored stress points, and performed necessary maintenance and adjustments during periods of downtime. 공시 • Dec 08
Cryomass Technologies Inc., Annual General Meeting, Jun 12, 2023 Cryomass Technologies Inc., Annual General Meeting, Jun 12, 2023, at 10:00 Mountain Daylight. 공시 • Aug 10
CryoMass Technologies Inc. Appoints Mike Stringile to Lead Global Sales CryoMass Technologies Inc. appointed Mike Stringile to lead its worldwide sales team as it prepares to launch its first commercial installation next month in Monterey, California. Mr. Stringile brings unsurpassed cannabis industry extraction knowledge and sales experience to CryoMass. Mike began his extraction career working in the oil and gas industry in Fort McMurray, Alberta, where he was immersed in the complex world of extracting hydrocarbons from oil sands. After spending more than seven years honing his technical knowledge of hydrocarbon extraction processes, Mike was given the opportunity to apply his extraction expertise to the burgeoning new cannabis industry. In November 2018, Mr. Stringile joined an upstart C02 extraction company based in Kelowna, British Columbia, called Vitalis Extraction Technologies. It didn't take long for Mike's expertise to pay off. Mike integrated his oil and gas industry knowledge into the design of their extractors, which resulted in the development of C02 extractors for the cannabis industry. Simultaneously Mike built an ancillary sales department that did much more than sell extractors; it sold much-needed extraction knowledge and process integration expertise to cannabis companies. In the first 18 months, Mike's sales division generated more than $18 million in revenues for Vitalis. Then in March 2020, during the Covid lockdowns, Mr. Stringile co-founded AGMS Solutions Inc., which continues to provide a comprehensive suite of extraction-oriented consulting services to the cannabis industry. AGMS quickly developed a worldwide network of cannabis cultivators, extractors, and finished goods producers seeking to avail themselves of advanced and customized extraction solutions. 공시 • Aug 06
Cryomass Technologies Inc. Prepares for the Market Launch of Its Revolutionary Trichome Separator CryoMass Technologies Inc. announced that rigorous testing of its patented cryogenic trichrome separation system has yielded results in all key areas of interest that either met or significantly surpassed pre-testing expectations. The Company is now busily preparing to deliver its first commercial unit to an operating partner based in the heart of the largest cannabis production region of the larger cannabis market, California. This Monterey-based company manufactures premium extracts for their own brand and several of the more prominent, better-known brands in California. Their extensive expertise in producing high-quality, standardized extracts should prove invaluable as company refine standard operating procedures (SOP) to guide product development for future customers. Together company are establishing a toll processing station at their sophisticated Monterey facility, where company expect to process cannabis on behalf of some of California's leading cannabis cultivators, many of which are already close business relationships. The Company is confident this partnership will begin generating revenues in the 4th quarter of 2022 and anticipate a steep ramp-up in revenues throughout 2023. The CryoMass system enables cannabis and hemp cultivators and processors to optimize and streamline their processes, thus dramatically reducing costs while simultaneously capturing approximately 97% of the active elements and increasing the purity and quality of the products sold to consumers. Testing Phase Highlights; When comparing the results of the patented CryoMass system to traditional trichome separation systems, there is no comparison. Based on the processing of 25,000 lbs. of biomass, here are the results of trichome separation system versus nine leading traditional systems that do not and cannot utilize patented cryogenic, solventless separation process: It is important to note that one of the key reasons the CryoMass system is so much more efficient from a process and cost-saving perspective is that it is, to the best of knowledge, the only continuous-feed separation system while all others are batch-feed systems. Although the Company's initial focus is on the cannabis and hemp sector, there is tremendous potential to generate important revenue streams from processing other high-value, trichrome-rich plants where similar cost savings and end-product improvements can be realized. 공시 • May 03
Cryomass Technologies Inc., Annual General Meeting, Jun 20, 2022 Cryomass Technologies Inc., Annual General Meeting, Jun 20, 2022, at 10:00 Mountain Daylight. Location: 1001 Bannock Street, Suite 612 Denver Colorado United States Agenda: To elect five directors to serve until the next annual meeting of stockholders and until their respective successors are duly elected and qualified; to ratify the appointment of BF Borgers, CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; to grant the Board of Directors the discretionary authority to amend the company’s articles of incorporation to effect a reverse stock split of the company’s common stock; and to consider other matters. 공시 • Aug 17
Andina Gold Corp. announced delayed 10-Q filing On 08/16/2021, Andina Gold Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Jan 22
American Cannabis Company, Inc. (OTCPK:AMMJ) entered into a non-binding letter of intent to acquire Good Meds and BOSM Labs Operating Division Assets from Andina Gold Corp. (OTCPK:AGOL). American Cannabis Company, Inc. (OTCPK:AMMJ) entered into a non-binding letter of intent to acquire Good Meds and BOSM Labs Operating Division Assets from Andina Gold Corp. (OTCPK:AGOL) on January 21, 2021. Assets includes one cultivation operation and one hydrocarbon extraction laboratory and production center. The transaction is expected to close in second quarter of 2021. 공시 • Oct 31
Andina Gold Corp. Announces Board Appointments Andina Gold Corp. announced further development of the company's focus and strategy. At its meeting on October 29, 2020, the Company's Board of Directors reaffirmed its August 11 decision to shift away from the U.S. cannabis market and toward exploration opportunities in previously inaccessible districts of Colombia's historically productive gold mining regions. At the August 11 meeting, as a step toward acting on its decision, the company added two Directors to its Board, Mr. Carlos Andrés Hernández and Mr. Gary Artmont, who brought extensive experience in Colombian mining and mineral exploration. The new directors broadened the Company's capabilities, which already included expertise in finance, capital market and international governmental and regulatory matters. Andina Gold's Colombian subsidiary, Andina Gold Colombia S.A.S., was duly established in August 2020 and now is qualified to conduct business in the country. 공시 • Jul 22
Redwood Green Corp. Elects Christopher A. Hansen as Chief Executive Officer Effective as of July 20, 2020, the Redwood Green Corp. elected Christopher A. Hansen as Chief Executive Officer. Mr. Hansen will not serve on the Company's Board of Directors.